The goal is to create new drugs for hemophilia, heart disease in infants, and Stargardt, a disease that causes blindness.
Gene-editing techniques are on the cusp of transitioning from science fiction to reality.
Bayer Partners With Gene-Editing Startup CRISPR To Develop New Drugs
Willoughby Avenue is a digital publisher and an independent agency with over twenty years of experience. We create branding, communication and memorable experiences for Brands of Color.
About Us
Culture
Art
Politics
History
Race
Community
Faith
